NYSE · Medical - Instruments & Supplies

BLCO (BLCO) Stock

$16.76 +0.48% NYSE: BLCO Healthcare

Valuation

MetricValue
Price$16.76
Market Cap$5.99B
P/E Ratio13.97
P/B Ratio0.84
P/S Ratio1.03
EPS (TTM)$0.00
52-Week High$18.92
52-Week Low$10.45
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-3.28%
ROA1.41%
ROCE2.88%
Gross Margin55.86%
Operating Margin5.91%
Net Margin-4.21%
Debt/Equity0.01
Current Ratio1.55

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.8B$3.8B$4.1B$4.8B$5.1B
Operating Profit$329.0M$207.0M$130.0M$162.0M$188.0M
Net Profit$182.0M$6.0M$-260.0M$-317.0M$-360.0M
EPS$0.52$0.04$-0.74$-0.90$-1.02
Op Margin8.7%5.5%3.1%3.4%3.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$10.8B$11.1B$13.4B$13.5B$14.0B
Total Liabilities$1.4B$4.0B$6.5B$6.9B$7.5B
Cash$174.0M$380.0M$334.0M$305.0M$383.0M
Borrowings$140.0M$2.6B$4.7B$4.9B$5.4B

Latest News

Bausch + Lomb Launches EyeGility™ Inserter Preloaded IOL Delivery System in the United States Business Wire · Jul 16, 2026 Ophthalmology Devices Market Report Released, Includes Profiles of EssilorLuxottica, Alcon, Bausch + Lomb, and 20 Others GlobeNewswire · Jul 13, 2026 Why Bausch + Lomb (BLCO) Stock Is Trading Lower Today StockStory · Jul 10, 2026 Sector Update: Healthcare Stocks Decline Late Afternoon MT Newswires · Jul 10, 2026 Sector Update: Healthcare Stocks Decline Friday Afternoon MT Newswires · Jul 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$873.0M$345.0M$-17.0M$232.0M$283.0M
Investing Cash Flow$-407.0M$-390.0M$-2.3B$-703.0M$-804.0M
Financing Cash Flow$-740.0M$-2.4B$-37.0M$-23.0M$-24.0M
Net Cash Flow$-61.0M$203.0M$-46.0M$-18.0M$81.0M
Free Cash Flow$680.0M$170.0M$-198.0M$-59.0M$-66.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.89
EV / EBITDA14.16
FCF Yield0.08%
Quick Ratio0.99
Interest Coverage0.44
Return 1Y14.79%
Return 3Y-21.89%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACLXArcellx, Inc. $115.07 +0.02% -28.27 $6.73B 0.00%
ARWR $86.01 +1.61% -7397.00 $12.12B 0.00%
CRSP $46.73 +0.41% -12.98 $4.51B 0.00%
GKOS $166.72 -1.07% -42.65 $9.83B 0.00%
MMSI $85.01 +1.99% 26.36 $5.07B 0.00%

About BLCO

BLCO stock trades at $16.76 with a market capitalization of $5.99B. The stock is valued at a price-to-earnings (P/E) ratio of 13.97, price-to-book of 0.84, price-to-sales of 1.03. Over the past 52 weeks the stock has ranged between $10.45 and $18.92, and currently trades 11.4% below its 52-week high.

On profitability, BLCO generates a return on equity (ROE) of -3.28%, return on capital employed of 2.88%, an operating margin of 5.91%, a net profit margin of -4.21%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides